CRISPR Therapeutics – CRSP: Short Squeeze bei der Schweizer Biotech-Aktie?
Short Float bei 29.37% Seit Jahren keine Gewinne bei CRISPR Therapeutics (CRSP). Insider kauft trotzdem! JETZT Pullback-Setup! CRISPR Therapeutics (CRSP) ...
Friday, January 23, 2026
Tag: CRSP
CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading
We recently published These 10 Stocks Surprisingly Lead Gains While Wall Street Naps. CRISPR Therapeutics AG (NASDAQ:CRSP) is one of this week’s ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.